Cite

HARVARD Citation

    Sayal, K. et al. (n.d.). Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer. International journal of gynecological cancer. 25 (6), p. . [Online]. 
  
Back to record